A Randomized Controlled Pilot Study Evaluating the Safety and Efficacy of Nifuroxazide in Patients with Ulcerative Colitis
Hayam Ali AlRasheed,1 Mahmoud S Abdallah,2,3 Eman El-Khateeb,4,5 Marwa Kamal,6 Sarah Alrubia,7 Amsha S Alsegiani,7 Tarek I Ahmed,8 Mostafa M Bahaa9 1Department of Pharmacy Practice, College of Pharmacy, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia; 2Department of Clinical Pharma...
Saved in:
| Main Authors: | AlRasheed HA, Abdallah MS, El-Khateeb E, Kamal M, Alrubia S, Alsegiani AS, Ahmed TI, Bahaa MM |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2025-06-01
|
| Series: | Drug Design, Development and Therapy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/a-randomized-controlled-pilot-study-evaluating-the-safety-and-efficacy-peer-reviewed-fulltext-article-DDDT |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effectiveness and safety of «Nifuroxazide-ECO» in therapy of escherichioses in children
by: N. V. Gonchar, et al.
Published: (2021-03-01) -
Nifuroxazide Pharmaceutical Preparations in the Russian Federation. Publication One: Nomenclature, Chemical and Pharmaceutical Characteristics of the Preparations’ Composition
by: V. I. Kocherovets, et al.
Published: (2021-10-01) -
Colo‐Protective Effects of Pentoxifylline Alone or in Combination With Mesalamine in Colitis Through Sphingosine Kinase 1/Sphingosine 1 Phosphate, and Zonula Occuldin 1 Pathways: New Molecular Approach
by: Fatemah A. Alherz, et al.
Published: (2025-06-01) -
Lactobacillus johnsonii alleviates colitis by TLR1/2-STAT3 mediated CD206+ macrophagesIL-10 activation
by: Ding-Jia-Cheng Jia, et al.
Published: (2022-12-01) -
Estimation of salivary IL-6 and calprotectin in patients with ulcerative colitis
by: Fadhel A. Abdullah, et al.
Published: (2024-12-01)